Learn more about whether Protagonist Therapeutics, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

We recently compiled a list of the 13 Best Dividend Growth Stocks With 10%+ Yearly Increases. In this article, we are going ...

ImmuPharma plc (LON:IMM – Get Free Report)’s stock price traded up 23.8% during trading on Saturday . The company traded as high as GBX 5.70 ($0.07) and last traded at GBX 4.83 ($0.06). 16,731,404 ...

ImmuPharma plc (LON:IMM – Get Free Report)’s share price shot up 23.8% on Saturday . The company traded as high as GBX 5.70 ($0.07) and last traded at GBX 4.83 ($0.06). 16,731,404 shares changed hands ...

Learn more about whether Protagonist Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on ...

More information about the 2025 AAAAI / WAO Joint Congress can be accessed here.

Hong Kong biotech start-up works with university partners to conduct global clinical trials studying prevalent eye diseases.

Novo Nordisk boasts 45 million customers using its drug, which has caused a revolution in weight-loss treatment. But competitors are nipping at its heels.